140
Participants
Start Date
September 1, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
June 30, 2025
Ropivacaine
300 mL of 0.25% ropivacaine, the mode was intermittent pumping, and the parameters were set as follows: 30 mL of the first dose, 5 mL/h of the background dose, and 10 mL of the pumping every 6h for the first 24 hours after the operation.
Sufentanil
Sufentanil 2.0 μg/kg, 0.9% saline diluted to 100 mL, background dose of 2 ml/h, no loading dose, activated after extubation and continued until 48 hours postoperatively.
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER